LSD1 Antikörper (C-Term)

Produktnummer ABIN356730

Produktdetails anti-LSD1 Antikörper

Target: LSD1 (KDM1A) (Lysine (K)-Specific Demethylase 1A (KDM1A))

Bindungsspezifität: C-Term

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LSD1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Enzyme Immunoassay (EIA)

Spezifität: This antibody is specific to LSD1 (C-term).

Aufreinigung: Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.

Immunogen: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human LSD1.

Isotyp: Ig Fraction

Anwendungsinformationen

Applikationshinweise: ELISA: 1/1,000. Western blot: 1/100-1/500. Immunohistochemistry: 1/50-1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.25 mg/mL

Buffer: PBS containing 0.09 % (W/V) Sodium Azide as preservative.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.

Details zu LSD1

Target: LSD1 (KDM1A) (Lysine (K)-Specific Demethylase 1A (KDM1A))

Andere Bezeichnung: AOF2 (KDM1A Produkte)

Synonyme: AOF2 antikoerper, BHC110 antikoerper, KDM1 antikoerper, LSD1 antikoerper, 1810043O07Rik antikoerper, AA408884 antikoerper, Aof2 antikoerper, D4Ertd478e antikoerper, Kdm1 antikoerper, Lsd1 antikoerper, mKIAA0601 antikoerper, DKFZp459N2450 antikoerper, RGD1562975 antikoerper, aof2 antikoerper, kdm1 antikoerper, wu:fb82e06 antikoerper, wu:fc51a02 antikoerper, wu:fj36a05 antikoerper, wu:fj66b06 antikoerper, KDM1A antikoerper, lsd1 antikoerper, xLSD1 antikoerper, AtLSD1 antikoerper, F9F13.30 antikoerper, F9F13_30 antikoerper, LESION SIMULATING DISEASE antikoerper, LESION SIMULATING DISEASE 1 antikoerper, lysine demethylase 1A antikoerper, lysine (K)-specific demethylase 1A antikoerper, lysine (K)-specific demethylase 1a antikoerper, LSD1 zinc finger family protein antikoerper, KDM1A antikoerper, Kdm1a antikoerper, kdm1a antikoerper, LSD1 antikoerper

Hintergrund: LSD1 is a histone demethylase that specifically demethylates 'Lys-4' of histone H3, a specific tag for epigenetic transcriptional activation, thereby acting as a corepressor. LSD1 contains a SWIRM domain, a FAD-binding motif, and an amine oxidase domain. This protein is a component of several histone deacetylase complexes, though it silences genes by functioning as a histone demethylase. It acts by oxidizing the substrate by FAD to generate the corresponding imine that is subsequently hydrolyzed. LSD1 demethylates both mono- and tri-methylted 'Lys-4' of histone H3. This protein may play a role in the repression of neuronal genes. Alone, it is unable to demethylate H3 'Lys-4' on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity. It may also demethylate 'Lys-9' of histone H3, a specific tag for epigenetic transcriptional repression, thereby leading to derepression of androgen receptor target genes.Synonyms: BRAF35-HDAC complex protein BHC110, Flavin-containing amine oxidase domain-containing protein 2, KIAA0601, LSD1, Lysine-specific histone demethylase 1

Gen-ID: 23028, 9606

UniProt: O60341

Pathways: Regulation of Hormone Metabolic Process, Regulation of Hormone Biosynthetic Process, Negative Regulation of intrinsic apoptotic Signaling, Warburg Effekt